Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

On the use of human mobility proxies for modeling epidemics.

Tizzoni M, Bajardi P, Decuyper A, Kon Kam King G, Schneider CM, Blondel V, Smoreda Z, González MC, Colizza V.

PLoS Comput Biol. 2014 Jul 10;10(7):e1003716. doi: 10.1371/journal.pcbi.1003716. eCollection 2014 Jul.

2.

Human mobility and time spent at destination: impact on spatial epidemic spreading.

Poletto C, Tizzoni M, Colizza V.

J Theor Biol. 2013 Dec 7;338:41-58. doi: 10.1016/j.jtbi.2013.08.032. Epub 2013 Sep 4.

PMID:
24012488
3.

Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm.

Tizzoni M, Bajardi P, Poletto C, Ramasco JJ, Balcan D, Gonçalves B, Perra N, Colizza V, Vespignani A.

BMC Med. 2012 Dec 13;10:165. doi: 10.1186/1741-7015-10-165.

4.

Heterogeneous length of stay of hosts' movements and spatial epidemic spread.

Poletto C, Tizzoni M, Colizza V.

Sci Rep. 2012;2:476. doi: 10.1038/srep00476. Epub 2012 Jun 27.

5.

Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic.

Bajardi P, Poletto C, Ramasco JJ, Tizzoni M, Colizza V, Vespignani A.

PLoS One. 2011 Jan 31;6(1):e16591. doi: 10.1371/journal.pone.0016591.

7.

Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic.

Balcan D, Colizza V, Singer AC, Chouaid C, Hu H, Gonçalves B, Bajardi P, Poletto C, Ramasco JJ, Perra N, Tizzoni M, Paolotti D, Van den Broeck W, Valleron A, Vespignani A.

PLoS Curr. 2009 Dec 7;1:RRN1133.

8.

Estimate of Novel Influenza A/H1N1 cases in Mexico at the early stage of the pandemic with a spatially structured epidemic model.

Colizza V, Vespignani A, Perra N, Poletto C, Gonçalves B, Hu H, Balcan D, Paolotti D, Van den Broeck W, Tizzoni M, Bajardi P, Ramasco JJ.

PLoS Curr. 2009 Nov 11;1:RRN1129.

9.

Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection.

Lombardi G, Garofoli F, Villani P, Tizzoni M, Angelini M, Cusato M, Bollani L, De Silvestri A, Regazzi M, Stronati M.

Eur J Clin Microbiol Infect Dis. 2009 Dec;28(12):1465-70. doi: 10.1007/s10096-009-0806-5. Epub 2009 Sep 11.

PMID:
19763643
10.

Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility.

Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, Ramasco JJ, Paolotti D, Perra N, Tizzoni M, Van den Broeck W, Colizza V, Vespignani A.

BMC Med. 2009 Sep 10;7:45. doi: 10.1186/1741-7015-7-45.

11.

Modeling vaccination campaigns and the Fall/Winter 2009 activity of the new A(H1N1) influenza in the Northern Hemisphere.

Bajardi P, Poletto C, Balcan D, Hu H, Goncalves B, Ramasco J, Paolotti D, Perra N, Tizzoni M, Van den Broeck W, Colizza V, Vespignani A.

Emerg Health Threats J. 2009;2:e11. doi: 10.3134/ehtj.09.011. Epub 2009 Nov 2.

12.

[Genotoxicity of surface water treated with different disinfectants using in situ plant tests].

Alberti A, Tizzoni M, Zani C, Feretti D, Gustavino B, Zerbini I, Nardi G, Monarca S.

Ann Ig. 2003 Nov-Dec;15(6):953-7. Italian.

PMID:
15049553
13.

Pharmacokinetics of omeprazole in cirrhotic patients.

Rinetti M, Regazzi MB, Villani P, Tizzoni M, Sivelli R.

Arzneimittelforschung. 1991 Apr;41(4):420-2.

PMID:
1859516
14.

The effect of aging on the pharmacokinetics of nizatidine.

Villani P, Regazzi MB, Pecorini M, Tizzoni M, Savio D.

Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:205-10.

PMID:
1820880
15.

Bioequivalency of three tableted gallopamil products.

Regazzi MB, Molinaro M, Daneri A, Tizzoni M, Legnazzi P.

Boll Chim Farm. 1989 May;128(5):173-6.

PMID:
2605029
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk